Slater & Gordon: UK Integration Progressing Well
Edison | Feb 22, 2014 11:16PM ET
Integrating well and on track
Slater & Gordon (SGH) has produced a strong performance in the half year to 31 December 2013, and has confidently reiterated its guidance for the year. The existing Australian and UK businesses continue to provide growth while the integration of fast-tracked UK acquisitions is proceeding well, with prospects of further growth. SGH is seeking to build a dominant direct to consumer legal business based on a leading brand; it estimates its UK consumer personal injuries market share has now reached c 5%, leaving it well positioned in a fast consolidating market.
H1 leaves full year well on track
With continuing organic growth and acquisitions integrating well, revenues grew 22.3% in H1, EBITDA margin, adjusted for acquisition costs, was an underlying 23.1%, cash flow from operations, at 91.5% of net profit, was ahead of the 70-80% target, and the interim dividend was increased 9.1% to 3.0 cents per share. Full year guidance was reiterated with a noticeable increase in confidence.
UK integration progressing well
Taylor Vintners, Goodman and Pickering have already been integrated on to a common practice system and rebranded S&G. The larger Fentons is undergoing a phased integration to mitigate risks, and is planned to join a new, common practice system (including the Pannone acquisition, expected to complete this month) in March 2015. The enlarged UK business expects to see a greater share of more complicated serious personal injury cases, with a corresponding increase in EBITDA margin. We now expect a pause in SGH’s UK acquisition programme as it integrates and grows its existing businesses, but a significant growth opportunity remains. The group’s UK market share of c 5% compares with a domestic Australian share of c 25%, while the addressable UK market is estimated to be four to five times larger.
Valuation: Shares have responded well
As the only directly quoted consumer law firm in the world there is little valuation comparison. The shares have responded well to the continued development of the group and the visibility of performance compared with more cyclical areas of the Australian equity market. The current FY15e EV/EBITDA ratio of 9.1x suggests near-term upside is more limited, but is not excessive given SGH’s room for growth in an economically-defensive industry. Our DCF valuation (see page 6) of A$4.92 per share equates to a 13.6x FY15 P/E ratio.
Get The News You Want
To Read the Entire Report Please Click on the pdf File Below
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.